Type 2 Diabetes
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.
Intensification of therapy within 6 months of metformin monotherapy failure resulted in rapid attainment of A1c goals.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.
The once-daily injection works to improve glycemic control.
A patient with type 2 diabetes is undergoing dialysis and needs to control his HbA1c levels while fasting during Ramadan.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesityJune 01, 2016
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patientsApril 20, 2016
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
A patient with type 2 diabetes presents with elevated microalbumin levels and a recent history of elevated glucose due to bedtime snacking.
High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.
The CPAP group had a larger decrease in HbA1c levels after 6 months.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
A statin plus extended-release niacin reduces apoB-48 concentrations in patients with type 2 diabetes, compared with a statin alone.
More than 60% of the 31,545 patients analyzed between 2001 and 2013 underwent HbA1c at least four times per year.
Breastfeeding for 2 or more months may reduce the odds of developing type 2 diabetes in mothers previously diagnosed with gestational diabetes.
Patients with type 2 diabetes and severe insulin resistance may require large doses of insulin to achieve glycemic control.
Three renal biomarkers - AKI, albuminuria, and eGFR - can predict adverse outcomes in diabetes, according to a study published in Diabetes Care.
A meta-analysis of 88 studies show a concrete link between current smokers and an elevated risk of type 2 diabetes.
Clinicians should screen all asymptomatic, obese adults for abnormal blood glucose levels, says the U.S. Preventative Services Task Force.
Daytime sleepiness and long naps may be associated with significantly increased risks of developing type 2 diabetes.
Almost half of adults in the United States have either type 2 diabetes or prediabetes, though many are undiagnosed.
SGLT2 receptor blockers are only approved for type 2 diabetes.
Glyxambi is adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
The FDA released a warning that DPP-4 inhibitors may lead to severe joint pain in patients with T2DM.
Using long-acting insulin in type 2 diabetes does not increase the risk for acute myocardial infarction.